Anticonvulsant and Antiepileptogenic Effects Mediated by Adeno-Associated Virus Vector Neuropeptide Y Expression in the Rat Hippocampus

Journal of Neuroscience

Volumn 24, Issue 12, 2004, Pages 3051-3059

  Richichi, Cristina ^a   Lin, En Ju D ^b   Stefanin, Daniela ^a   Colella, Daniele ^a   Ravizza, Teresa ^a   Grignaschi, Giuliano ^a   Veglianese, Pietro ^a   Sperk, Günther ^c   During, Matthew J ^b   Vezzani, Annamaria ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Epilepsy; Fascia dentata; Gene; Kainic acid; Kindling; Seizure

Indexed keywords

KAINIC ACID; NEUROPEPTIDE Y; PARVOVIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DENTATE GYRUS; ELECTROENCEPHALOGRAM; EPILEPSY; EPILEPTIC STATE; EPILEPTOGENESIS; GENE EXPRESSION; GENE TRANSFER; HIPPOCAMPUS; INTERNEURON; KINDLING; MALE; MOSSY FIBER; NONHUMAN; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT; SEIZURE; SEROTYPE; SUBICULUM; TRANSGENE;

ANIMALS; DEPENDOVIRUS; DISEASE MODELS, ANIMAL; ELECTROENCEPHALOGRAPHY; EPILEPSY; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HIPPOCAMPUS; INJECTIONS, INTRAVENTRICULAR; KAINIC ACID; KINDLING, NEUROLOGIC; MALE; NEUROPEPTIDE Y; RATS; RATS, SPRAGUE-DAWLEY; SEIZURES; TREATMENT OUTCOME;

EID: 12144291522     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.4056-03.2004     Document Type: Article

References (54)

1. Amaral DG, Witter MP (1995) Hippocampal formation. In: Hippocampus (Paxinos G, ed), pp 443-493. New York: Academic.
2. Baraban SC, Hollopeter G, Erickson JC, Schwartzkroin PA, Palmiter RD (1997) Knock-out mice reveal a critical antiepileptic role for neuropeptide Y. J Neurosci 17:8927-8936.
3. Bellmann R, Widmann R, Olenik C, Meyer DK, Maas D, Marksteiner J, Sperk G (1991) Enhanced rate of expression and biosynthesis of neuropeptide Y after kainic acid-induced seizures. J Neurochem 56:525-530.
4. Bregola G, Dumont Y, Fournier A, Zucchini S, Quirion R, Simonato M (2000) Decreased levels of neuropeptide Y5 receptor binding sites in two experimental models of epilepsy. Neuroscience 98:697-703.
5. Burgess TL, Kelly RB (1987) Constitutive and regulated secretion of proteins. Annu Rev Cell Biol 3:243-293.
6. Clark KR, Sferra TJ, Lo W, Qu G, Chen R, Johnson PR (1999) Gene transfer into the CNS using recombinant adeno-associated virus: analysis of vector DNA forms resulting in sustained expression. J Drug Target 7:269-283.
7. Colmers WF, Bleakman D (1994) Effects of neuropeptide Y on the electrical properties of neurons. Trends Neurosci 17:373-379.
8. Day R, Schafer MK, Watson SJ, Chretien M, Seidah NG (1992) Distribution and regulation of the prohormone convertases PC1 and PC2 in the rat pituitary. Mol Endocrinol 6:485-497.
9. de Lanerolle NC, Kim JH, Robbins RJ, Spencer DD (1989) Hippocampal interneuron loss and plasticity in human temporal lobe epilepsy. Brain Res 495:387-395.
10. DePrato Primeaux S, Holmes PV, Martin RJ, Dean RG, Edwards GL (2000) Experimentally induced attenuation of neuropeptide-Y gene expression in transgenic mice increases mortality rate following seizures. Neurosci Lett 287:61-64.
11. During MJ (1997) Adeno-associated virus as a gene delivery system. Adv Drug Deliv Rev 27:83-94.
12. During MJ, Young D, Baer K, Lawlor P, Klugmann M (2003) Development and optimization of adeno-associated virus vector transfer into the central nervous system. Methods Mol Med 76:221-236.
13. El Bahh B, Herzog HH, Beck-Sickinger AG, Doods H, Colmers WF (2002) Y2 receptors are necessary and sufficient for anticonvulsant presynaptic action of NPY in rat and mouse hippocampus. Soc Neurosci Abstr 28:148.12.
14. Furtinger S, Pirker S, Czech T, Baumgartner C, Ransmayr G, Sperk G (2001) Plasticity of Y1 and Y2 receptors and neuropeptide Y fibers in patients with temporal lobe epilepsy. J Neurosci 21:5804-5812.
15. Gobbi M, Gariboldi M, Piwko C, Hoyer D, Sperk G, Vezzani A (1998) Distinct changes in peptide YY binding to, and mRNA levels of, Y1 and Y2 receptors in the rat hippocampus associated with kindling epileptogenesis. J Neurochem 70:1615-1622.
16. Greber S, Schwarzer C, Sperk G (1994) Neuropeptide Y inhibits potassium-stimulated glutamate release through Y2 receptors in rat hippocampal slices in vitro. Br J Pharmacol 113:737-740.
17. Gruber B, Greber S, Rupp E, Sperk G (1994) Differential NPY mRNA expression in granule cells and interneurons of the rat dentate gyrus after kainic acid injection. Hippocampus 4:474-482.
18. Haberman RP, Samulski RJ, McCown TJ (2003) Attenuation of seizures and neuronal death by adeno-associated virus vector galanin expression and secretion. Nat Med 9:1076-1080.
19. Husum H, Gruber SH, Bolwig TG, Mathe AA (2002) Extracellular levels of NPY in the dorsal hippocampus of freely moving rats are markedly elevated following a single electroconvulsive stimulation, irrespective of anticonvulsive Y1 receptor blockade. Neuropeptides 36:363-369.
20. Kaplitt MG, Leone P, Samulski RJ, Xiao X, Pfaff DW, O'Malley KL, During MJ (1994) Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nat Genet 8:148-154.
21. Kopp J, Nanobashvili A, Kokaia Z, Lindvall O, Hokfelt T (1999) Differential regulation of mRNAs for neuropeptide Y and its receptor subtypes in widespread areas of the rat limbic system during kindling epileptogenesis. Brain Res Mol Brain Res 72:17-29.
22. Laurberg S (1979) Commissural and intrinsic connections of the rat hippocampus. J Comp Neurol 184:685-708.
23. Lin EJ, Richichi C, Young D, Baer K, Vezzani A, During MJ (2003) Recombinant AAV-mediated expression of galanin in rat hippocampus suppresses seizure development. Eur J Neurosci 18:1-6.
24. Marcinkiewicz M, Seidah NG, Chretien M (1996) Implications of the subtilisin/kexin-like precursor convertases in the development and function of nervous tissues. Acta Neurobiol Exp 56:287-298.
25. Marksteiner J, Ortler M, Bellmann R, Sperk G (1990) Neuropeptide Y biosynthesis is markedly induced in mossy fibers during temporal lobe epilepsy of the rat. Neurosci Lett 112:143-148.
26. Marsh DJ, Baraban SC, Hollopeter G, Palmiter RD (1999) Role of the Y5 neuropeptide Y receptor in limbic seizures. Proc Natl Acad Sci USA 96:13518-13523.
27. Masseroli M, Bollea A, Bendotti C, Forloni G (1993) In situ hybridization histochemistry quantification: automatic count on single cell in digital image. J Neurosci Methods 47:93-103.
28. Mastakov MY, Baer K, Kotin RM, During MJ (2002) Recombinant adeno-associated virus serotypes 2- and 5-mediated gene transfer in the mammalian brain: quantitative analysis of heparin co-infusion. Mol Ther 5:371-380.
29. Mathern GW, Babb TL, Pretorius JK, Leite JP (1995) Reactive synaptogenesis and neuron densities for neuropeptide Y, somatostatin, and glutamate decarboxylase immunoreactivity in the epileptogenic human fascia dentata. J Neurosci 15:3990-4004.
30. Mazarati A, Wasterlain CG (2002) Anticonvulsant effects of four neuropeptides in the rat hippocampus during self-sustaining status epilepticus. Neurosci Lett 331:123-127.
31. Milner TA, Wiley RG, Kurucz OS, Prince SR, Pierce JP (1997) Selective changes in hippocampal neuropeptide Y neurons following removal of the cholinergic septal inputs. J Comp Neurol 386:46-59.
32. Mitchell J, Cook I, Hervey V (1997) Effect of seizures on hippocampal peptidergic neurons. Neuropathol Appl Neurobiol 23:299-306.
33. Passini MA, Watson DJ, Vite CH, Landsburg DJ, Feigenbaum AL, Wolfe JH (2003) Intraventricular brain injection of adeno-associated virus type 1 (AAV1) in neonatal mice results in complementary patterns of neuronal transduction to AAV2 and total long-term correction of storage lesions in the brains of beta-glucuronidase-deficient mice. J Virol 77:7034-7040.
34. Patrylo PR, van den Pol AN, Spencer DD, Williamson A (1999) NPY inhibits glutamatergic excitation in the epileptic human dentate gyrus. J Neurophysiol 82:478-483.
35. Pedrazzini T, Pralong F, Grouzmann E (2003) Neuropeptide Y: the universal soldier. Cell Mol Life Sci 60:350-377.
36. Racine RJ (1972) Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr Clin Neurophysiol 32:281-294.
37. Redrobe JP, Dumont Y, St-Pierre JA, Quirion R (1999) Multiple receptors for neuropeptide Y in the hippocampus: putative roles in seizures and cognition. Brain Res 848:153-166.
38. Reibel S, Larmet Y, Carnahan J, Marescaux C, Depaulis A (2000) Endogenous control of hippocampal epileptogenesis: a molecular cascade involving brain-derived neurotrophic factor and neuropeptide Y. Epilepsia 41 [Suppl 6]: S127-S133.
39. Reibel S, Nadi S, Benmaamar R, Larmet Y, Carnahan J, Marescaux C, Depaulis A (2001) Neuropeptide Y and epilepsy: varying effects according to seizure type and receptor activation. Peptides 22:529-539.
40. Ribak CE, Seress L (1983) Five types of basket cell in the hippocampal dentate gyrus: a combined Golgi and electron microscopic study. J Neurocytol 12:577-597.
41. Schwarzer C, Sperk G, Samanin R, Rizzi M, Gariboldi M, Vezzani A (1996) Neuropeptides-immunoreactivity and their mRNA expression in kindling: functional implications for limbic epileptogenesis. Brain Res Brain Res Rev 22:27-50.
42. Schwarzer C, Kofler N, SperkG (1998) Up-regulation of neuropeptide Y-Y2 receptors in an animal model of temporal lobe epilepsy. Mol Pharmacol 53:6-13.
43. Sloviter RS (1991) Permanently altered hippocampal structure, excitability, and inhibition after experimental status epilepticus in the rat: the "dormant basket cell" hypothesis and its possible relevance to temporal lobe epilepsy. Hippocampus 1:41-66.
44. Smialowska M, Sopala M, Tokarski K (1996) Inhibitory effect of intrahippocampal NPY injection on amphetamine-induced behavioural activity. Neuropeptides 30:67-71.
45. Sperk G, Marksteiner J, Gruber B, Bellmann R, Mahata M, Ortler M (1992) Functional changes in neuropeptide Y- and somatostatin-containing neurons induced by limbic seizures in the rat. Neuroscience 50:831-846.
46. Sundstrom LE, Brana C, Gatherer M, Mepham J, Rougier A (2001) Somatostatin- and neuropeptide Y-synthesizing neurones in the fascia dentata of humans with temporal lobe epilepsy. Brain 124:688-697.
47. Thorsell A, Michalkiewicz M, Dumont Y, Quirion R, Caberlotto L, Rimondini R, Mathe AA, Heilig M (2000) Behavioral insensitivity to restraint stress, absent fear suppression of behavior and impaired spatial learning in transgenic rats with hippocampal neuropeptide Y overexpression. Proc Natl Acad Sci USA 97:12852-12857.
48. Vezzani A, Sperk G, Colmers WF (1999a) Neuropeptide Y: emerging evidence for a functional role in seizure modulation. Trends Neurosci 22:25-30.
49. Vezzani A, Conti M, De Luigi A, Ravizza T, Moneta D, Marchesi F, De Simoni MG (1999b) Interleukin-1β immunoreactivity and microglia are enhanced in the rat hippocampus by focal kainate application: functional evidence for enhancement of electrographic seizures. J Neurosci 19:5054-5065.
50. Vezzani A, Rizzi M, Conti M, Samanin R (2000) Modulatory role of neuropeptides in seizures induced in rats by stimulation of glutamate receptors. J Nutr 130 [Suppl 4] 41:1046S-1048S.
51. Vezzani A, Michalkiewicz M, Michalkiewicz T, Moneta D, Ravizza T, Richichi C, Aliprandi M, Mule F, Pirona L, Gobbi M, Schwarzer C, Sperk G (2002) Seizure susceptibility and epileptogenesis are decreased in transgenic rats overexpressing neuropeptide Y. Neuroscience 110:237-243.
52. Weinshenker D, Szot P, Miller NS, Rust NC, Hohmann JG, Pyati U, White SS, Palmiter RD (2001) Genetic comparison of seizure control by norepinephrine and neuropeptide Y. J Neurosci 21:7764-7769.
53. Woldbye DP (1998) Antiepileptic effects of NPY on pentylenetetrazole seizures. Regul Pept 75-76:279-282.
54. Xu R, Janson CG, Mastakov M, Lawlor P, Young D, Mouravlev A, Fitzsimons H, Choi KL, Ma H, Dragunow M, Leone P, Chen Q, Dicker B, During MJ (2001) Quantitative comparison of expression with adeno-associated virus (AAV-2) brain-specific gene cassettes. Gene Ther 8:1323-1332.